DexCom (DXCM) Reiterated at Buy by Benchmark After Investor Event

May 15, 2026 7:54 AM EDT Send to a Friend
Benchmark analyst Bruce Jackson reiterated a Buy rating and $77.00 price target on DexCom (NASDAQ: DXCM).The analyst commented, "Dexcom hosted ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login